Related Experiment Video
Updated: Jun 10, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)
N Kikkawa1, T Hanazawa, L Fujimura
1Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Background:
Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive malignancy with one of the worst prognoses among all head and neck cancers. Greater understanding of the pertinent molecular oncogenic pathways could help improve diagnosis, therapy, and prevention of this disease. The aim of this study was to identify tumour-suppressive microRNAs (miRNAs), based on miRNA expression signatures from clinical HSCC specimens, and to predict their biological target genes.
Methods:
Expression levels of 365 human mature miRNAs from 10 HSCC clinical samples were screened using stem-loop real-time quantitative PCR. Downregulated miRNAs were used in cell proliferation assays to identify a tumour-suppressive miRNA. Genome-wide gene expression analyses were then performed to identify the target genes of the tumour-suppressive miRNA.
Results:
Expression analysis identified 11 upregulated and 31 downregulated miRNAs. Gain-of-function analysis of the downregulated miRNAs revealed that miR-489 inhibited cell growth in all head and neck cancer cell lines examined. The gene PTPN11 coding for a cytoplasmic protein tyrosine phosphatase containing two Src Homology 2 domains was identified as a miR-489-targeted gene. Knockdown of PTPN11 resulted in the inhibition of cell proliferation in head and neck SCC cells.
Conclusion:
Identification of the tumour-suppressive miRNA miR-489 and its target, PTPN11, might provide new insights into the underlying molecular mechanisms of HSCC.
Insights
Researchers identified miR-489 as a tumor-suppressive microRNA in hypopharyngeal squamous cell carcinoma (HSCC). This microRNA targets PTPN11, inhibiting cancer cell growth and offering potential new therapeutic strategies for HSCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive cancer with a poor prognosis.
- Understanding molecular pathways is crucial for improving HSCC diagnosis, therapy, and prevention.
Purpose of the Study:
- Identify tumor-suppressive microRNAs (miRNAs) in HSCC.
- Predict biological target genes of identified miRNAs.
Main Methods:
- Screened miRNA expression in 10 HSCC clinical samples using real-time quantitative PCR.
- Utilized cell proliferation assays to identify tumor-suppressive miRNAs.
- Performed genome-wide gene expression analysis to find miRNA target genes.
Main Results:
- Identified 11 upregulated and 31 downregulated miRNAs.
- miR-489 demonstrated tumor-suppressive activity by inhibiting head and neck cancer cell growth.
- PTPN11 was identified as a direct target of miR-489; its knockdown also inhibited cancer cell proliferation.
Conclusions:
- miR-489 acts as a tumor suppressor in HSCC.
- PTPN11 is a validated target of miR-489.
- These findings offer novel insights into HSCC molecular mechanisms and potential therapeutic targets.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
